Mosby's drugconsult.

Bioequivalence studies in drug development : methods and applications /
by: Hauschke, Dieter
Published: (2007)

Guidance for industry : statistical approaches to establishing bioequivalence.
Published: (2001)

Bioequivalence and statistics in clinical pharmacology /
by: Patterson, Scott D.
Published: (2006)

Pharmacology and the healthcare professional.
Published: (2011)

Guidance for industry : submission of summary bioequivalence data for ANDAs.
Published: (2009)

Drug reference guide to brand names and active ingredients /
by: Pagliaro, Louis A.
Published: (1986)

Guidance : topical dermatologic corticosteroids, in vivo bioequivalence.
Published: (1995)

Guidance for industry : bioequivalence recommendations for specific products.
Published: (2007)

Resistant prices : a study of competitive strains in the antibiotic markets /
by: Brooke, Paul A.
Published: (1975)

Orange book : approved drug products with therapeutic equivalence evaluations.

Design and analysis of bioavailability and bioequivalence studies /
by: Chow, Shein-Chung, 1955-
Published: (2009)

Frecuentes preguntas acerca de las drogas genéricas.
Published: (2004)

Approved drug products with therapeutic equivalence evaluations.
Published: (1985)

Approved drug products with therapeutic equivalence evaluations.

Guidance for industry : clozapine tables, in vivo bioequivalence and in vitro dissolution testing.
Published: (2005)

Guidance for industry : waiver of in vivo bioavailability studies for immediate-release soild oral dosage forms based on a biopharmaceutics classification system.
Published: (2000)

Guidance for industry : nonsterile semisolid dosage forms : scale-up and postapproval changes : chemistry, manufacturing, and controls : in vitro release testing and in vivo bioequivalence documentation.
Published: (1997)

Generic drug product development : solid oral dosage forms /
Published: (2005)

Hechos sobre los medicamentos genéricos.
Published: (2006)

Facts about generic drugs.
Published: (2006)

Design and analysis of bioavailability and bioequivalence studies /
by: Chow, Shein-Chung, 1955-
Published: (2000)

Pharmaceutical bioequivalence /
Published: (1991)

Guidance for indusry : bioavailability and bioequivalence studies for nasal aerosols and nasal sprays for local action.
Published: (2003)

Bioequivalence studies in drug development : methods and applications /
by: Hauschke, Dieter
Published: (2007)

Generic drugs : stakeholders views on improving FDA's information on patents : report to congressional committees /
Published: (2023)

Guidance for industry : SUPAC-MR : modified release solid oral dosage forms : scale-up and postapproval changes, chemistry, manufacturing and controls, in vitro dissolution testing and in vivo bioequivalence documentation.
Published: (1997)

The effect of generic drug competition on generic drug prices during the Hatch-Waxman 180-day exclusivity period /
by: Olson, Luke M., et al.
Published: (2013)

Prescription drugs : implications of drug labeling and off-label use : statement of Sarah F. Jagger, Director of Health Services Quality and Public Health Issues, Health, Education, and Human Services Division, before the Subcommittee on Human Resources and Intergovernmental Relations, Committee on Government Reform and Oversight, U.S. House of Representatives /
by: Jagger, Sarah F.
Published: (1996)

Brands, generics, prices and quality; the prescribing debate after a decade.
Published: (1971)

Making Objective Drug Evidence Revisions for New Labeling Act of 2020 : report (to accompany H.R. 5668) (including cost estimate of the Congressional Budget Office).
Published: (2020)

Guidance for industry : immediate release solid oral dosage forms : scale-up and postapproval changes, chemistry, manufacturing and controls, in vitro dissolution testing, and in vivo bioequivalence documentation.
Published: (1995)

The marketing of generic drugs : a guide to counter-strategies for the technology intensive pharmaceutical companies /
by: James, Barrie G.
Published: (1981)

Increasing generic drug utilization : saving money for patients : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Ninth Congress, first session, May 18, 2005.
Published: (2005)

Increasing generic drug utilization : saving money for patients : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Ninth Congress, first session, May 18, 2005.
Published: (2005)

FDA's generic drug approval process : hearings before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundred First Congress, first session.
Published: (1989)

Authorized generic drugs : short-term effects and long-term impact.
Published: (2011)